Navigation Links
First in the World Live Case Using New Technology Demonstrates Shorter Procedure Time
Date:11/5/2007

Ablation Frontiers, Inc. Participates in the Heart Rhythm Congress 2007

Live EP Cases in Birmingham, UK

CARLSBAD, Calif., Nov. 5 /PRNewswire/ -- Ablation Frontiers, Inc., a privately-held medical device company, announced today its successful first public broadcast of a procedure using the company's novel Catheter Ablation System on October 31. Performed by Dr. Lucas Boersma of the St. Antonius Hospital in Nieuwegein, The Netherlands, the System was used to isolate heart tissue causing a potentially dangerous irregular heart rhythm. The process was transmitted to an audience of heart specialists in Birmingham, United Kingdom, as part of the 2007 Heart Rhythm Congress. Professor John Morgan of the Southampton General Hospital -- a member of the Heart Rhythm Congress organizing committee -- accompanied Dr. Boersma in performing the procedure.

The 60-year old male patient was diagnosed with paroxysmal atrial fibrillation (AF), a recurrent electrical "short circuit" in one of the upper heart chambers, approximately 2 years ago. In March 2007, however, his diagnosis worsened to persistent atrial fibrillation, defined as AF which is sustained beyond seven days. He has suffered from episodic heart palpitations and dyspnea -- all common symptoms of this arrhythmia. "I would often be out of breath and sometimes feel my heart beating much faster than normal," said the patient.

The minimally-invasive procedure was performed in the Cardiac Catheterization Laboratory. Dr. Boersma began by inserting the Pulmonary Vein Ablation Catheter (PVAC(TM)) into the patient's right leg and maneuvering up to the heart by way of a large vein. The multi-electrode circular tip catheter was used to diagnose and treat the cardiac tissue responsible for the irregular heart rhythm, which was located in the left atrium of the heart, near the pulmonary veins. Simultaneously applying radiofrequency (RF) energy to all of the electrodes with the Ablation F
'/>"/>

SOURCE Ablation Frontiers, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ash., Dec 1 Edifecs, Inc., the pro...dernization solutions announced an enhanced releas...IPAA 4010A1 to HIPAA 5010 migrations. XEngine Tran...ion maps, allows generation of test data and permi...production, thus addressing most requirements for ...
(Date:12/1/2009)...elopment of simple screening test, expert says , ...a finding that could lead to a simple blood test t...entified immune system markers that indicate early... cancer. , The researchers examined gene expres...th non-small cell lung cancer and a control group ...
(Date:12/1/2009)...ould benefit from liver surgery after chemo, study...News) -- A CT scan of liver tumors caused by the s...l survival after chemotherapy, researchers report....emotherapy has been shown to improve survival in p...roduce better results in patients having surgery t...
(Date:12/1/2009)... because pandemic,s course remains unpredictable ,... U.S. health official said Tuesday that H1N1 swine...y, but many experts agreed the virus could return ...despread in 32 states -- down from 43 states the w... U.S. Centers for Disease Control and Prevention (...
(Date:12/1/2009)... 2009)The Clinical Research Building (CRB), at the...s been honored for its sustainability components. ...ablished by the U.S. Green Building Council and ve...te (GBCI). LEED is the nation,s preeminent program...en buildings., "Having a LEED certified building ...
Breaking Medicine News(10 mins):Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2
...A new model to predict the spread of emerging dise...Italy, and France. The model, described in the onl...ealthcare professionals advance warning of the pat...2002-2003, revealing just how vulnerable we might ...
...NEY, Australia, Nov. 20 Open access online journa...ne) has released a special,nanotubes research edit...ollaborative research project that has been invest...on,[ http://www.azonano.com/nanotechnology%20journ...
...TA ANA, Calif., Nov. 20 NNN Healthcare/Office REI...e acquisition closed on,November 15, 2007. Northm...uare-foot,multi-tenant medical office building in ... from the North Fulton,Regional Hospital campus. T...
...RAMENTO, Calif., Nov. 20 Californians are known f...the next several days they,will have an opportunit...ystem into something that everyone can feel better...question of how effective health care reform can b...
...NDALE, Wash., Nov. 20 WELLESSE ALL DAY Energy(TM)...Seattle Marathon. WELLESSE,will be showcasing WELL...or energy and endurance.(+) (Photo: http://www.n...ndurance.(+) You may be a marathon athlete, a stu...
...CROSS, Ga., Nov. 20 Immucor, Inc. (Nasdaq:,BLUD),...-reagent systems to,the blood transfusion industry... to join Immucor as Vice President and Chief Finan...d agreed to,remain until a replacement was hired. ...
Other Medicine News:Health News:SARS: a model disease 2Health News:Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal 2Health News:NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia 2Health News:NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia 3Health News:California's Huge Health Care Opportunity 2Health News:WELLESSE ALL DAY ENERGY(TM) - Sponsors of the UW Medical Center 2007 Seattle Marathon 2Health News:Immucor, Inc. Appoints New Chief Financial Officer 2
(Date:12/1/2009)..., ALBUQUERQUE, N.M., Dec. 1 Exag...ratory that discovers, develops and markets propri...nt of Scott Glenn as chairman of the company,s boa... Prior to joining Exagen, Glenn was managing partn...number of successful biomedical companies includin...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-Asia/ -...rovider of biopharmaceutical products in China, an...hase order for its H1N1 vaccine, PANFLU.1(TM),fro...hnology for the national,purchase plan. Under this...,additional one million doses of PANFLU.1 (TM) (15...
(Date:12/1/2009)... , REDWOOD CITY, Calif., Dec. 1 /PRNewswire/ ...ts relationship and the signing of its second agre...s Ltd., the world,s largest generic drug manufactu...harmaceutical products. Codexis announced an earl...the new agreement, Teva will use Codexis biocataly...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Codexis Expands Collaboration with Teva 2Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems Inc 51916 1Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems Inc 51916 2Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 1Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 2Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz 51911 3National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 1National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 2
...s published in the journal Blood found 92 percent ...hromboses, CHESHIRE, Conn., Aug. 20 Patients wit...2 percent reduction in the,incidence of life-threa...t,with Soliris(TM) (eculizumab), according to an a...ine in Blood, the journal of the American Society ...
...H MEETING, Pa., Aug. 1 Genaera,Corporation (Nasda...,MedImmune, Inc. has initiated a multi-dose, Phase...Ab) targeting interleukin-9 (IL-9) in adults with,...ose-escalation study is,designed to evaluate the s...tibody. This trial is the second Phase 2a study cu...
Other Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 2Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 3Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 4
BTC/1Q - Cast Aluminum Base - Model 1Q70-R
BTC/1Q - Cast Aluminum Base - Model 1Q70
BTT/1P - Tubular Base - Model 1P63
BTT/1P - Tubular Base - Model 1P62
Medicine Products: